comparemela.com

Denyse Dabrowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results

Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

John Lehner, Former State Street and BNY Mellon Executive, Joins FundGuard as President

Model N, Inc : Model N and Global Pricing Innovations Announce Strategic Partnership

Model N, Inc.: Model N and Global Pricing Innovations Announce Strategic Partnership Life Sciences Technology Leaders to Deliver Scalable Solution Enabling Best-in-Class, Data-Powered Insights Around International Pricing and Market Access Decision-Making Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced a strategic life sciences industry partnership with Global Pricing Innovations (GPI), a market leader in analytics, insights and innovative solutions that help life sciences companies achieve day-to-day operational improvement and market access excellence. The partnership with Model N delivers scalable technology and services that enable data-powered insights, achieving measurable impact on global customer pricing and market access decision-making.

Octapharma Selects Model N Revenue Cloud for Life Sciences

Press release content from Business Wire. The AP news staff was not involved in its creation. Octapharma Selects Model N Revenue Cloud for Life Sciences January 7, 2021 GMT SAN MATEO, Calif. (BUSINESS WIRE) Jan 7, 2021 Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that specialty manufacturer Octapharma USA, Inc. has selected the Model N Revenue Management Cloud for Life Sciences, including Model N’s Provider Management and Provider Intelligence applications, as its revenue management system of record. Working diligently to combat the worldwide COVID-19 pandemic through the development of plasma derived blood product therapies, fast-growing Octapharma USA will leverage the Model N solution as part of an overall reengineering of its legacy, manually-based revenue management processes.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.